Ottawa, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The global preclinical advanced cell models market is driven by increasing research and development, growing use of cell and gene therapies, expanding ...

Early detection of safety liabilities of new therapies is a critical biopharmaceutical challenge. Addressing this challenge could significantly advance drug discovery. Advanced human cell models, ...

Drug discovery requires experimental systems that more accurately capture the complexity of human tissues. However, animal models and conventional cell culture approaches often lack the physiological ...

From self-driving laboratories to advanced cellular models, ELRIG Drug Discovery 2026 showcases technologies helping researchers generate better data, evaluate drug candidates and improve early ...

Want to learn how to create 3D organoids using the latest Incucyte workflow? Join Kalpana Barnes from Sartorius AG in our Teach Me in 10 video and discover how to embed organoids, optimize experiments ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced it has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company ...

Induced pluripotent stem cells (iPSCs) have transformed research in regenerative medicine, disease modelling, drug discovery, and personalised medicine. But anyone who has worked with iPSCs knows the ...

Advanced cell models, including 2D cultures, iPSCs, and organoids, have become essential to modern research. However, for many laboratories, the main challenge is not the complexity of the biology, ...

Advanced cell models promise better insight into how the human brain functions and fails by mimicking living neural tissue. But not all 3D models probe the same biological questions. The architecture ...

UCLA researchers used patient-derived stem cells to model how gene variants that cause developmental and epileptic encephalopathy type 13, a rare genetic childhood epilepsy, affect different regions ...